MA-CHAOSSEARCH
Today, ChaosSearch, a leader in data analytics, announced the integration of Chaos LakeDB with Amazon Bedrock from Amazon Web Services (AWS), a fully managed service that makes foundation models (FMs) from leading AI companies accessible via an API to build and scale generative AI applications. This integration is designed to transform the way organizations leverage generative artificial intelligence (AI) to interact with their unified data lakes for observability, security lakes, and application insight use cases, providing clients with enhanced simplicity, choice, and security. Chaos LakeDB customers can select any large language model (LLM) from Amazon Bedrock’s choice of high-performing FMs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231127237186/en/
The combination of generative AI and ChaosSearch’s unified data lake offers new possibilities for enterprises. Chaos LakeDB opens these opportunities while delivering cost-effective scaling and simplifying working with data pipelines, data preparation, and data islands. It integrates with and orchestrates pre-trained generative AI models as a complement to Search and SQL analytics, creating an ideal launch point for enterprises to immediately realize efficiency improvements across observability, security lake, and application insight use cases.
"As a long-term partner with ChaosSearch, we've witnessed firsthand the transformative impact of their technology on our data analytics capabilities," said Jimmy McDermott of PATHWAYos. "The integration of Chaos LakeDB with Amazon Bedrock represents a leap forward in our ability to harness the full power of generative AI within our data strategy. The seamless and secure interaction with LLMs has allowed us to tap into a new dimension of data intelligence, optimizing our workflows, and enhancing our decision-making process. ChaosSearch's vision for the future of data interaction is not just a promise; it's a reality that's delivering exceptional value to our organization."
Chaos LakeDB integration with Amazon Bedrock allows users to engage with their data through a conversational AI interface, leveraging public and private LLM models. By utilizing prompt engineering and orchestrating chain-of-thought interaction, users can converse directly with their data with enhanced security. The integration leverages AWS’s data security and privacy best practices and no confidential or proprietary data is shared with the LLM. Furthermore, this design removes the challenges of complex and costly model training while preventing data hallucinations.
With the integration of Chaos LakeDB with Amazon Bedrock, organizations can further isolate their data in a private workspace where all exchanges of information between the database and the LLM are private. None of the customer’s data is used to train or fine-tune the underlying LLM. In essence, the LLM is private to the user account.
Chaos LakeDB’s integration with Amazon Bedrock delivers:
- Intuitive Data Exploration: Understand complex data effortlessly with ChaosSearch AI Assistant's ability to suggest, process queries, and surface crucial insights, eliminating the barrier of advanced analytical skills.
- Code Co-pilot: Receive smart support for writing and refining Elastic and SQL queries, with the assurance of secure processing.
- Enhanced Team Collaboration: Promote efficient teamwork and shared understanding through user-friendly data sharing and exploration tools, suitable for various expertise levels.
- Immediate Insights: Obtain real-time visibility into key operational areas such as system behavior, security monitoring, and application performance.
"AI is transforming business intelligence," said Dr. Sherry Marcus, director of Applied Science of Amazon Bedrock and Amazon Titan at Amazon Web Services. "The Chaos LakeDB integration with Amazon Bedrock is simplifying how customers engage with and analyze their data—and with the security and scalability that enterprises demand. Using conversational queries to interact with their data, customers will be able to glean deeper insights and make more informed decisions. We look forward to seeing how the power of generative AI will enhance customers’ business strategies."
"At ChaosSearch, we are deeply passionate about empowering our clients to conquer the ever-growing mountain of data analytics challenges," said Thomas Hazel, founder and CTO of ChaosSearch. "The integration of Chaos LakeDB with Amazon Bedrock is a critical milestone on our ambitious roadmap. It's designed to provide a straightforward, high-impact entry point for organizations embarking on their generative AI journey. We're not just enhancing our platform; we're providing a key that unlocks high-value insights while simplifying the journey to scale analytics. Our dedication to innovation is relentless, and this integration exemplifies our commitment to delivering not just solutions but pathways to transformation and growth that redefine analytics at scale for our clients."
An innovative solution for data interaction and analysis, Chaos LakeDB's integration with Amazon Bedrock is a powerful tool for businesses worldwide. As the company moves forward with its dynamic roadmap, clients can anticipate even more advanced features and capabilities tailored to their specific needs. As clients look to train their own models or augment existing FMs, Chaos LakeDB will play a critical role for creation, test data access and exporting for training and deploying generative AI models in production at scale without breaking the bank.
Chaos LakeDB and the integration with Amazon Bedrock is available in early access. Contact us, for more information or to request a demo.
About ChaosSearch:
ChaosSearch is redefining the boundaries of data analytics by offering transformative solutions that empower businesses to make data-driven decisions with unparalleled efficiency. Our ethos is centered on simplifying complexity and turning challenges into opportunities. Chaos LakeDB is at the forefront of revolutionizing data lake architectures in the AI-driven era. By seamlessly transforming cloud storage into a dynamic analytical database, it integrates diverse data streams, streamlines intricate pipelines, and delivers at scale actionable insights through Search+SQL+GenAI analytics. By eliminating manual redundancies and activating static data lakes, Chaos LakeDB provides businesses with both real-time and historical intelligence. As champions of innovation, ChaosSearch is dedicated to delivering tools that not only meet but also anticipate the evolving needs of modern businesses. Dive into a world where data is not just stored but becomes a dynamic force driving growth and innovation.
Leading cloud-based organizations, including Equifax, Cisco, Revinate, and Digital River, trust the ChaosSearch Cloud Data Platform. For more information, visit ChaosSearch.io or follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231127237186/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom